Off-Label Use of Cancer Drugs: A Benchmark Is Established

被引：14
|
作者：
Krzyzanowska, Monika K. [1 ,2 ,3 ]
机构：
[1] Princess Margaret Hosp, Toronto, ON, Canada
[2] Inst Clin Evaluat Sci, Toronto, ON, Canada
[3] Univ Toronto, Toronto, ON, Canada
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2013年 / 31卷 / 09期
关键词：
BEVACIZUMAB; THERAPY; SAFETY;
D O I：
10.1200/JCO.2012.46.9460
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1125 / 1127
页数：3
相关论文
共 50 条
  • [21] Off-label use of rituximab in a tertiary Queensland hospital
    Butterly, S. J.
    Pillans, P.
    Horn, B.
    Miles, R.
    Sturtevant, J.
    INTERNAL MEDICINE JOURNAL, 2010, 40 (06) : 443 - 452
  • [22] Off-Label Use of Gastrointestinal Medications in the Intensive Care Unit
    Barletta, Jeffrey F.
    Lat, Ishaq
    Micek, Scott T.
    Cohen, Henry
    Olsen, Keith M.
    Haas, Curtis E.
    JOURNAL OF INTENSIVE CARE MEDICINE, 2015, 30 (04) : 217 - 225
  • [23] Off-Label Use of Recombinant Factor VIIa in Pediatric Patients
    McQuilten, Zoe K.
    Barnes, Chris
    Zatta, Amanda
    Phillips, Louise E.
    PEDIATRICS, 2012, 129 (06) : E1533 - E1540
  • [24] Off-label Avastin use under investigation
    Reactions Weekly, 2011, 1371 (1) : 3 - 3
  • [25] Retapamulin Prescriptions and Monitored Off-Label Use
    Mundy, Linda M.
    Sampson, Tim
    Logie, John W.
    PEDIATRIC DRUGS, 2014, 16 (04) : 331 - 336
  • [26] Evaluating the Use of Dalbavancin for Off-Label Indications
    Taylor, Katherine
    Williamson, John
    Luther, Vera
    Stone, Tyler
    Johnson, James
    Gruss, Zachary
    Russ-Friedman, Courtney
    Ohl, Chris
    Beardsley, James
    INFECTIOUS DISEASE REPORTS, 2022, 14 (02) : 266 - 272
  • [27] Off-label use of atomoxetine in adults: is it safe?
    Dadashova, Rana
    Silverstone, Peter H.
    MENTAL ILLNESS, 2012, 4 (02): : 96 - 101
  • [28] Frequency of the off-label use of monoclonal antibodies in clinical practice: a systematic review of the literature
    Zarkali, Angeliki
    Karageorgopoulos, Drosos E.
    Rafailidis, Petros I.
    Falagas, Matthew E.
    CURRENT MEDICAL RESEARCH AND OPINION, 2014, 30 (03) : 471 - 480
  • [29] Analysis of effectiveness of off-label use of Bevacizumab in recurrent breast and ovarian cancer
    Araque, P.
    Alanon, A. M.
    Carreras, M. J.
    Peran, L.
    Fernandez, M. A.
    Calleja, M. A.
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2011, 33 (02) : 451 - 451
  • [30] Regulatory Actions on the Off-Label Use of Prescription Drugs: Ongoing Controversy and Contradiction in 2009 and 2010
    Fairman, Kathleen A.
    Curtiss, Frederic R.
    JOURNAL OF MANAGED CARE PHARMACY, 2010, 16 (08): : 629 - 639
12345